slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 88,861-88,890
Pages 3,225
Rows per page 30
Component
88,861-88,890 of 96,741
03
The slide provides a high-level summary of the company's pipeline and financial runway.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
14
The slide uses a timeline-based diagram to illustrate the clinical trial protocol.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Traction1 hit
18
The slide outlines the strategic rationale for a specific clinical trial phase.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
27
The slide highlights a strategic partnership and the resulting research pipeline.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
05
The slide uses a product photo to demonstrate the scale and form factor of the device.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
08
Includes a detailed biological mechanism diagram showing the interaction of KOR, dynorphin, and neurotransmitters.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
14
The table uses a color-coded legend for 'Degree of preference' (High, Medium, Low).Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
17
Includes a biological pathway diagram showing V1aR antagonism and downstream signaling effects.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
18
The slide uses a 'Signal Seeking' framework to justify clinical development decisions based on effect size.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
19
The slide uses a biological pathway diagram to illustrate the mechanism of action of the drug candidate.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
21
The slide uses a biological pathway diagram to illustrate the mechanism of action (PAM) and the pathology of schizophrenia.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
22
Includes a biological mechanism diagram showing the inhibition of TDP-43 phosphorylation by NMRA-CK1δ.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
23
MVAE stands for Multimodal Variational Autoencoder.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
24
The slide uses a biological pathway diagram to illustrate the mechanism of action of the drug candidate.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
25
Includes a detailed biological pathway diagram illustrating the mechanism of action.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
26
The slide uses a linear process flow (Challenge -> Toolbox -> Value) to explain the company's methodology.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
13
Uses a pendulum metaphor to illustrate patient maturity and its impact on profitability.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Action1 hit
06
The slide uses a Gantt-style visualization for drug development stages.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
08
The slide uses a simple comparison framework to highlight clinical benefits.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
09
The slide uses a comparison framework to justify the use of alpha-emitting isotopes in targeted radiotherapy.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Problem1 hit
11
The slide uses a comparison table to validate the market potential of the radiopharmaceutical space by highlighting a competitor's success.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
13
The slide uses a Kaplan-Meier curve to contrast Lutathera against a control group, highlighting the clinical limitation of the current standard of care.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The chart compares median progression vs median survival in months across three patient cohorts (Pancreatic, GI, Overall).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
18
Waterfall plot displays individual patient responses; benchmarking table compares ORR against historical standards.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
23
The slide highlights that 47% of SCLC samples show some level of SSTR2 expression, with 27% showing high expression.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
31
Includes IHC staining images and a waterfall plot showing tumor shrinkage.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
35
The slide uses a longitudinal imaging sequence to demonstrate drug efficacy/retention.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
37
The slide lists 24 investor logos/names.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
06
The slide uses a bar chart to represent asset growth over time, with logos marking the founding years of subsidiaries.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit
23
The slide uses a hub-and-spoke diagram to visualize the ecosystem, with VinFast at the center.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit